CSIMarket
 


Lazuriton Nano Biotechnology (u.s.a.) Inc.  (LNBI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

LNBI's Income from Cont. Operations Growth by Quarter and Year

Lazuriton Nano Biotechnology (u.s.a.)'s Income from Cont. Operations results by quarter and year




LNBI Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -0.02 -0.02 -
III Quarter September - -0.02 -0.02 0.00
II Quarter June -0.01 -0.02 -0.02 0.00
I Quarter March -0.02 -0.03 -0.12 0.00
FY   -0.03 -0.09 -0.18 -



LNBI Income from Cont. Operations second quarter 2019 Y/Y Growth Comment
Lazuriton Nano Biotechnology (u.s.a.) Inc. in the second quarter recorded loss from continued operations of $ -0.01 millions.

According to the results reported in the second quarter, Lazuriton Nano Biotechnology (u.s.a.) Inc. achieved the best Income from Cont. Operations growth in Biotechnology & Drugs industry. While Lazuriton Nano Biotechnology (u.s.a.) Inc.' s Income from Cont. Operations no change of % ranks overall at the positon no. in the second quarter.




LNBI Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Lazuriton Nano Biotechnology (u.s.a.)'s second quarter 2019 Income from Cont. Operations $ -0.01 millions LNBI's Income Statement
Lazuriton Nano Biotechnology (u.s.a.)'s second quarter 2018 Income from Cont. Operations $ -0.02 millions Quarterly LNBI's Income Statement
New: More LNBI's historic Income from Cont. Operations Growth >>


LNBI Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Lazuriton Nano Biotechnology (u.s.a.)'s Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LNBI's II. Quarter Q/Q Income from Cont. Operations Comment
Even if Lazuriton Nano Biotechnology (u.s.a.) Inc. in the II. Quarter 2019 admitted loss from continued operations of $ -0.01 millions, it should be point out, that those numbers show recovery in contrast to the -0.02 millions in the first quarter.

Within Biotechnology & Drugs industry Lazuriton Nano Biotechnology (u.s.a.) Inc. achieved highest sequential Income from Cont. Operations growth. While Lazuriton Nano Biotechnology (u.s.a.)'s Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LNBI's II. Quarter Q/Q Income from Cont. Operations Comment
Even if Lazuriton Nano Biotechnology (u.s.a.) Inc. in the II. Quarter 2019 admitted loss from continued operations of $ -0.01 millions, management point out, that those numbers show slight up side relative to the -0.02 millions in the first quarter.

Within Biotechnology & Drugs industry Lazuriton Nano Biotechnology (u.s.a.) Inc. achieved highest sequential Income from Cont. Operations growth. While Lazuriton Nano Biotechnology (u.s.a.)'s Income from Cont. Operations growth quarter on quarter, overall rank is .


Lazuriton Nano Biotechnology (u.s.a.)'s 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
12 Months Ending
Cumulative Income from Cont. Operations 12 Months Ending $ -0.08 $ -0.08 $ -0.09 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Lazuriton Nano Biotechnology (u.s.a.) Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Lazuriton Nano Biotechnology (u.s.a.) Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Drugs Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
LNBI's Income from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for LNBI's Competitors
Income from Cont. Operations Growth for Lazuriton Nano Biotechnology (u.s.a.)'s Suppliers
Income from Cont. Operations Growth for LNBI's Customers

You may also want to know
LNBI's Annual Growth Rates LNBI's Profitability Ratios LNBI's Asset Turnover Ratio LNBI's Dividend Growth
LNBI's Roe LNBI's Valuation Ratios LNBI's Financial Strength Ratios LNBI's Dividend Payout Ratio
LNBI's Roa LNBI's Inventory Turnover Ratio LNBI's Growth Rates LNBI's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2019
Select Medical Holdings Corp -0.95 %$ -0.946 millions
Prestige Consumer Healthcare Inc -1.18 %$ -1.175 millions
Abiomed Inc -1.27 %$ -1.269 millions
Encompass Health Corporation -1.77 %$ -1.770 millions
Zoetis Inc -2.88 %$ -2.880 millions
Electromed Inc -2.88 %$ -2.883 millions
Pra Health Sciences Inc -2.90 %$ -2.902 millions
Hca Healthcare Inc -4.04 %$ -4.037 millions
Amgen Inc -5.10 %$ -5.096 millions
Molecular Templates Inc -5.59 %$ -5.591 millions
Tenax Therapeutics Inc -5.87 %$ -5.871 millions
Quest Diagnostics Inc -6.01 %$ -6.009 millions
Anika Therapeutics Inc -6.51 %$ -6.510 millions
Standard Diversified Inc -6.74 %$ -6.739 millions
National Research Corporation -6.98 %$ -6.983 millions
Chemed Corporation -7.72 %$ -7.717 millions
Exelixis Inc -9.66 %$ -9.660 millions
Zynex Inc -10.59 %$ -10.587 millions
Catalent Inc -14.03 %$ -14.027 millions
Edwards Lifesciences Corporation -14.29 %$ -14.291 millions
Charles River Laboratories International inc -16.16 %$ -16.161 millions
Syneos Health Inc -16.73 %$ -16.726 millions
Hologic Inc -16.83 %$ -16.829 millions
Henry Schein Inc -17.69 %$ -17.688 millions
Acadia Healthcare Company Inc -18.15 %$ -18.151 millions
Utah Medical Products Inc -18.18 %$ -18.175 millions
Laboratory Corporation Of America Holdings -18.54 %$ -18.539 millions
Innoviva inc -18.64 %$ -18.643 millions
Tivity Health Inc -20.04 %$ -20.041 millions
Biotelemetry Inc -20.53 %$ -20.529 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CASY's Profile

Stock Price

CASY's Financials

Business Description

Fundamentals

Charts & Quotes

CASY's News

Suppliers

CASY's Competitors

Customers & Markets

Economic Indicators

CASY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071